Value
- Base
- 18.9
- Cagr
- 4.9
- Currency
- USD
- Forecast
- 27.8
- Unit
- Billion
Graph-backed node
The global statin market is expected to experience steady and sustained growth during the forecast period from 2026 to 2033. Valued at approximately USD 18.9 billion in 2025, the market is projected to reach nearly USD 27.8 billion by 2033, registering a CAGR of around 4.9%. Market growth is being driven by the rising prevalence of cardiovascular diseases, increasing incidence of hypercholesterolemia, growing geriatric population, and expanding awareness regarding preventive cardiovascular care and cholesterol management worldwide.
The global statin market is expected to experience steady and sustained growth during the forecast period from 2026 to 2033. Valued at approximately USD 18.9 billion in 2025, the market is projected to reach nearly USD 27.8 billion by 2033, registering a CAGR of around 4.9%. Market growth is being driven by the rising prevalence of cardiovascular diseases, increasing incidence of hypercholesterolemia, growing geriatric population, and expanding awareness regarding preventive cardiovascular care and cholesterol management worldwide.
The global statin market was valued at approximately USD 18.9 billion in 2025.
The market is expected to reach nearly USD 27.8 billion by 2033.
The global statin market is projected to expand at a CAGR of around 4.9% from 2026 to 2033.
Key growth drivers include the rising prevalence of cardiovascular diseases, increasing incidence of hypercholesterolemia, growing aging population, expanding awareness of preventive healthcare, and wider availability of affordable generic statins.
Environment: live
Freshness: 2026-06-12T19:44:36+00:00
Resolved node: MIMR-node_5a8653e
Statsfocus
https://statsfocus.com
Knowledge graph of market intelligence